54767414MMY3014 (Perseus)

54767414MMY3014 (Perseus)

A Phase 3 Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) vs VELCADE, Lenalidomide, and Dexamethasone (VRd) in Subjects With Previously Untreated Multiple Myeloma Who Are Eligible for High-dose Therapy


Study treatment


Inclusion criteria


Exclusion criteria


Participating sites

Link